Drug recall · June 25, 2014
Captomer-250 [succinic acid recall
Why: Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1
- Lots / codes
All lot codes
- Quantity
- unknown
- Company
- Thorne Research Inc, Sandpoint, ID
- Distribution
- Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.
- Initiated
- June 12, 2014 · Voluntary: Firm initiated
- Classified
- June 13, 2014
- Reported
- June 25, 2014
- Ended
- October 15, 2014
- How notified
- Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.